Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Moderate to severe pain Age: Adult |
Dose: Sublingual – 200-400 micrograms Frequency: every 6-8 hours |
|
Indication: Premedication Age: Adult |
Dose: Sublingual – 400 micrograms |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Moderate to severe pain Age: Child |
Dose: Sublingual – 100 micrograms Frequency: every 6–8 hours |
|
Indication: Moderate to severe pain Age: Child |
Dose: Sublingual – 100–200 micrograms Frequency: every 6–8 hours |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal Impairment |
Dose: Not specified Note: Avoid use or reduce dose; opioid effects increased and prolonged; increased cerebral sensitivity |
Administration
- Take on empty stomach
- Wait 2 hours after meals
Side Effect
- Sedation (2/3 of patients)
- Dizziness
- Headache
- Hypotension
- Hypoventilation
- Miosis
- Nausea
- Sweating
- Vertigo
- Vomiting
- Abdominal cramps
- Amblyopia
- Apnea
- Blurred vision
- Bradycardia
- Coma
- Confusion
- Conjunctivitis
- Constipation
- Cyanosis
- Depersonalization
- Diplopia
- Dreaming
- Dry mouth
- Dyspepsia
- Dyspnea
- Electrocardiographic (ECG) abnormalities
- Euphoria
- Fatigue
- Flatulence
- Hallucinations
- Hypertension
- Injection-site reactions
- Malaise
- Mental depression
- Mydriasis
- Nervousness
- Paresthesia
- Pruritus
- Psychosis
- Respiratory depression
- Slurred speech
- Tachycardia
- Urticaria
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
CYP3A4 inducers or inhibitors
|
Plasma-buprenorphine concentrations may be affected
|
|
Alcohol, Anaesthetics, Anxiolytics, Hypnotics, TCAs, Antipsychotics (Haloperidol, Risperidone, Quetiapine, Olanzapine, Clozapine, Aripiprazole)
|
Enhanced depressant effects
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Acute Alcoholism, Head Injuries
|
Can worsen CNS depression
|
|
Increased Intracranial Pressure, Comatose Patients
|
Can worsen brain condition
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.